Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3240 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.81 USD | +0.63% | +11.09% | +34.36% | +278.74% | 342.41 M USD | ||
| 3250 |  OABI OmniAb, Inc. - Common Stock | 2.34 USD | +0.86% | -3.70% | +1.30% | +11.96% | 339.24 M USD | ||
| 3251 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.91 USD | -3.64% | -2.02% | +50.78% | +162.16% | 339.19 M USD | ||
| 3262 |  IRD Opus Genetics, Inc. - Common Stock | 4.08 USD | +0.74% | -1.45% | +0.49% | +9.68% | 332.09 M USD | ||
| 3272 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.32 USD | 0.00% | +0.76% | +9.09% | -23.26% | 329.07 M USD | ||
| 3305 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.35 USD | -0.42% | +13.53% | +48.73% | +422.22% | 316.22 M USD | ||
| 3329 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.99 USD | +1.53% | +1.27% | +10.22% | +15.32% | 307.98 M USD | ||
| 3330 |  HELP Cybin Inc. - Common Stock | 5.96 USD | -1.16% | -7.31% | +47.16% | -33.56% | 307.73 M USD | ||
| 3343 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.65 USD | -4.62% | +2.48% | 0.00% | +83.33% | 305.72 M USD | ||
| 3351 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | -0.22% | +5.02% | +90.08% | +113.95% | 302.94 M USD | ||
| 3370 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.88 USD | -0.51% | +1.84% | +14.12% | +57.72% | 296.68 M USD | ||
| 3381 |  MGNX MacroGenics, Inc. - Common Stock | 4.63 USD | -2.53% | +1.31% | +18.11% | +210.74% | 294.30 M USD | ||
| 3387 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.96 USD | -0.90% | -1.87% | +42.08% | +8.73% | 292.64 M USD | ||
| 3388 |  FBRX Forte Biosciences, Inc. - Common Stock | 21.07 USD | -5.30% | -0.14% | +33.44% | -28.21% | 292.57 M USD | ||
| 3392 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.49 USD | +0.54% | +0.54% | +17.21% | +7.46% | 290.77 M USD | ||
| 3423 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.30 USD | -4.22% | +33.05% | +82.35% | -7.00% | 277.03 M USD | ||
| 3432 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.42 USD | -9.36% | -17.97% | -9.02% | +27.37% | 274.05 M USD | ||
| 3438 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.41 USD | -1.16% | +2.71% | +1.19% | -31.53% | 271.59 M USD | ||
| 3442 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.02 USD | -1.46% | +2.02% | +22.42% | -0.98% | 266.71 M USD | ||
| 3443 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.16 USD | -2.21% | -21.42% | -18.53% | +79.98% | 266.56 M USD |
Notícias Biotechnology Stocks
Tarsus Pharmaceuticals adquire iRenix por US$ 75 milhões à vista
TD Cowen reitera recomendação de compra para Prime Medicine após vitória em arbitragem
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |